Successes & Challenges

Our 2009 Successes

Continued to develop what could be the first new medicine in nearly 40 years to fight tuberculosis. When it is approved, a royalty-free license will make the drug available at low cost in developing countries. (See Novel Partnerships Evolve Drug Development)
Over the past 24 months, Johnson & Johnson Patient Assistance Foundation, Inc. provided more than 1.7 million units of medicine to over 300,000 patients.
Contributed $588.1 million in cash and products toward nearly 650 philanthropic programs in more than 50 countries, impacting tens of millions of lives worldwide.
Was a founding sponsor of text4baby, a program that aims to reduce infant mortality by providing health information and resources via text messages to expectant women and new moms. (See Patient Safety and Education)
Announced support for the Physician Payments Sunshine Act of 2009 and will begin voluntary disclosure of payments to physicians. Disclosure by our U.S. Pharmaceutical companies will begin in 2010 and by our Medical Devices and Diagnostics companies by 2011.
Began a materiality assessment to help identify matters that could affect our ability to execute our business strategy and the degree to which our Company can impact them.

Reduced CO₂ emissions from our facilities worldwide by 15.9 percent vs. 1990 and generated 39 percent of our energy from renewable energy sources—a total of 1,460 GWH.
Opened a state-of-the-art research facility in Spring House, Pa., that achieved the first LEED Gold certification for a Johnson & Johnson laboratory facility. (See Building Sustainable Facilities)
Established a corporate policy mandating that all new construction projects be LEED-certified. Additionally, we are certifying existing buildings using LEED requirements, including our world headquarters in New Brunswick, N.J.
Continued encouraging our suppliers to join the Carbon Disclosure Project’s Supply Chain program; by the end of 2009, more than 80 percent of those we approached have chosen to participate.
Assessed more than 85 percent of our 700 external manufacturers against our Standards for Responsible External Manufacturing. Our goal is to assess 100 percent by the end of 2010.
Made progress in meeting our Healthy Planet 2010 and Healthy People 2012 goals. (See Healthy Planet 2010 and Employee Health and Wellness, respectively.)

Strengthened core businesses and invested in the launches of a number of newly approved innovative products. Invested another $7 billion in R&D.
Emerged from 2009 stronger than we were a year earlier, with outstanding new products, robust pipelines and talented people working in a streamlined organization with more resources for growth.
Advanced pipelines through internal development and continued to acquire, invest in and collaborate with other companies to generate new platforms for growth. From 2008 through 2009, made eight major acquisitions and invested in several strategic transactions. (See Discovering and Developing Products)
Expanded our global presence, including building operations and enhancing our reach in the BRIC countries – Brazil, Russia, India and China—and other fast-growing developing markets.
Participated in shaping health care reform legislation in the U.S. and in shaping health care policy around the world, in keeping with our vision. (See Working for Better Health Care Systems)
Initiated Sustainability Councils to coordinate sustainability practices and efforts across our businesses in areas such as marketing, packaging, product stewardship, emerging issues and occupational safety.
Created the Procurement Sustainability Initiative to leverage the purchasing power of Johnson & Johnson and drive sustainable business practices through our supply chain.